Pet Therapy Effects on Pain, Emotional and Physiological Responses in Children Undergoing Allergy Testing
Launched by MEHTAP METİN KARAASLAN · Mar 12, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how pet therapy, specifically using betta fish, can help reduce pain and emotional stress in young children undergoing allergy testing. Allergy tests, like the Skin Prick Test (SPT), are important for diagnosing allergies but can be stressful for kids, especially those aged 3 to 6. The research will involve 80 children who will be randomly divided into two groups: one experiencing pet therapy during the test and the other not. The goal is to see if being around fish can make the children feel better emotionally and physically during the procedure.
To be eligible for this study, children must be between 3 to 6 years old, have no previous allergy testing, and have stable health without chronic illnesses. Additionally, their mothers must be able to communicate and agree to participate. Families will be asked to join the study if they meet these criteria, and participants can expect to take part in a friendly environment where their emotional and physical responses will be carefully monitored. The findings from this trial could help develop better ways to ease children's anxiety during medical procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • No previous allergy testing
- • 3-6 years old
- • Stable hemodynamics
- • No chronic disease
- • The child has no intellectual or neurological disability
- • The mother has no obstacle to communication
- • Mother is literate
- • Families and children agree to participate in the study.
- Exclusion Criteria:
- • The child does not meet the inclusion criteria
- • The mother does not meet the inclusion criteria
- • Child's and mother's unwillingness to participate in the study
About Mehtap Meti̇n Karaaslan
Mehtap Metin Karaaslan is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on enhancing patient outcomes, Ms. Karaaslan leads initiatives that prioritize rigorous study design, ethical standards, and regulatory compliance. Her expertise spans various therapeutic areas, and she fosters collaboration among multidisciplinary teams to ensure the successful execution of clinical trials. Through her leadership, she aims to contribute significantly to the development of novel therapies and improve the overall landscape of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported